Entity
Description
  • Value proposition

    Transforming life sciences with cutting-edge proteomics technology and solutions

    The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented.

    Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.

    Our Solutions

    We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts.

    Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human and non-human species.

    Our Technology

    Biognosys is the leading inventor and developer of mass spectrometry-based proteomics solutions. With market leading proteome coverage and sample throughput we enable simultaneous quantification of thousands of proteins across thousands of samples.

    Our Facility

    From our global headquarters just outside of Zurich, we operate one of the largest high-end mass spectrometry laboratories worldwide for Large-Scale Discovery Proteomics contract research.

    Our Data Competence

    Biognosys has analyzed a vast amount of proteomics data and developed an industry-leading understanding of the proteome. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.

    Global Presence

    Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys today is an established leader in next-generation proteomics. With employees based across Switzerland, Europe, and US, and an extensive network of collaborators and distributors, Biognosys supports a global customer base of life science researchers across industry and academia.

    Mass Spectrometry, Hyper Reaction Monitoring (HRM), Proteome Profiling, Biomarker Discovery and Validation, Limited Proteolysis, Data Analytics, Artificial Intelligence, Machine Learning, Contract Research Services, Proteomics Services, Proteomics Software, Proteomics Kits, Oncology, Neuroscience, Immunology, Rare Diseases, Chronic Diseases, Drug Discovery, Pre-clinical research, Clinical studies, Targeted Proteomics, Discovery Proteomics, and Quantitative Protein Analysis

  • Global Proteomics | Next-Generation Proteomics | Proteomic Solutions

    Biognosys is a leading Global Proteomics company that offers Next Generation Proteomics Solutions based on proprietary mass spectrometry technology.

  • https://biognosys.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Amazon Web Services (AWS)
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Other

16 Jul 2024


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care
Other

2 May 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

13 Feb 2024


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

10 Dec 2023


Similar entities
Loading...
Loading...
Social network dynamics